PureTech Health (PRTC) Competitors

Schrödinger (NASDAQ:SDGR) and PureTech Health (NASDAQ:PRTC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, community ranking, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

Is SDGR or PRTC more profitable?

PureTech Health has a net margin of 0.00% compared to Schrödinger's net margin of -91.84%. PureTech Health's return on equity of 0.00% beat Schrödinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrödinger	-91.84%	-35.77%	-24.51%
PureTech Health	N/A	N/A	N/A

Does the MarketBeat Community favor SDGR or PRTC?

Schrödinger received 46 more outperform votes than PureTech Health when rated by MarketBeat users. Likewise, 57.89% of users gave Schrödinger an outperform vote while only 45.00% of users gave PureTech Health an outperform vote.

Company	Underperform	Outperform
Schrödinger	Outperform Votes 55 57.89%	Underperform Votes 40 42.11%
PureTech Health	Outperform Votes 9 45.00%	Underperform Votes 11 55.00%

Which has higher valuation and earnings, SDGR or PRTC?

Schrödinger has higher revenue and earnings than PureTech Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrödinger	$207.54M	7.02	$40.72M	-$2.57	-7.77
PureTech Health	$3.33M	139.50	-$65.70M	N/A	N/A

Do insiders and institutionals hold more shares of SDGR or PRTC?

79.1% of Schrödinger shares are held by institutional investors. Comparatively, 0.0% of PureTech Health shares are held by institutional investors. 8.6% of Schrödinger shares are held by insiders. Comparatively, 5.3% of PureTech Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Do analysts recommend SDGR or PRTC?

Schrödinger presently has a consensus price target of $32.29, suggesting a potential upside of 61.75%. PureTech Health has a consensus price target of $45.00, suggesting a potential upside of 132.68%. Given PureTech Health's stronger consensus rating and higher possible upside, analysts clearly believe PureTech Health is more favorable than Schrödinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrödinger	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	3.00
PureTech Health	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.50

Does the media prefer SDGR or PRTC?

In the previous week, Schrödinger had 4 more articles in the media than PureTech Health. MarketBeat recorded 6 mentions for Schrödinger and 2 mentions for PureTech Health. Schrödinger's average media sentiment score of 1.00 beat PureTech Health's score of 0.93 indicating that Schrödinger is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrödinger	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PureTech Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, SDGR or PRTC?

Schrödinger has a beta of 1.62, meaning that its share price is 62% more volatile than the S&P 500. Comparatively, PureTech Health has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500.

Summary

Schrödinger beats PureTech Health on 10 of the 16 factors compared between the two stocks.